Literature DB >> 12927782

Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes.

Alexander Rouvinski1, Inbar Gahali-Sass, Ilana Stav, Esther Metzer, Henri Atlan, Albert Taraboulos.   

Abstract

Components of caveolae and lipid rafts are characterized by their buoyancy after detergent extraction. Using flotations in density gradients, we now show that non-raft membrane molecules are also associated with detergent-insoluble, buoyant assemblies. When Triton X-100 cellular extracts were spun to equilibrium in Nycodenz, only components of classical rafts floated. In contrast, with the zwitterionic detergent CHAPS, non-raft residents such as calnexin and APP also buoyed. When CHAPS extracts were spun in non-equilibrium (velocity) conditions, some raft components rapidly exited the input fractions while other raft markers and non-raft molecules remained relatively immobile. This pointed to size heterogeneities of CHAPS-insoluble complexes. Combined velocity/equilibrium gradients broadly divided CHAPS-insoluble membrane complexes into three size categories, which all contained cholesterol and the glycosphingolipid GM1. Large complexes were enriched in caveolin and ESA. Medium size complexes were enriched in PrP, whereas small complexes contained non-raft proteins, PrP, and some ESA. While Alzheimer's APP was primarily confined to small assemblies, a portion of its glycosylated form did buoy with large complexes. Large CHAPS-insoluble complexes resemble, but are not equal to, classical rafts. These findings extend considerably the range of detergent-insoluble membranal domains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927782     DOI: 10.1016/s0006-291x(03)01470-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

2.  Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins.

Authors:  Hagit Achdout; Irit Manaster; Ofer Mandelboim
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

3.  Expression profile of flotillin-2 and its pathophysiological role after spinal cord injury.

Authors:  José M Santiago; Aranza I Torrado; Luz C Arocho; Odrick R Rosas; Ana E Rodríguez; Franchesca König Toro; Iris K Salgado; Yaría Arroyo Torres; Walter I Silva; Jorge D Miranda
Journal:  J Mol Neurosci       Date:  2012-08-10       Impact factor: 3.444

4.  Caveolin 2 regulates endocytosis and trafficking of the M1 muscarinic receptor in MDCK epithelial cells.

Authors:  Miriam Shmuel; Efrat Nodel-Berner; Tehila Hyman; Alexander Rouvinski; Yoram Altschuler
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

5.  Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts.

Authors:  Je-Seong Won; Yeong-Bin Im; Mushfiquddin Khan; Miguel Contreras; Avtar K Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-02-05       Impact factor: 5.372

6.  Cholesterol-dependent energy transfer between fluorescent proteins-insights into protein proximity of APP and BACE1 in different membranes in Niemann-Pick type C disease cells.

Authors:  Bjoern von Einem; Petra Weber; Michael Wagner; Martina Malnar; Marko Kosicek; Silva Hecimovic; Christine A F von Arnim; Herbert Schneckenburger
Journal:  Int J Mol Sci       Date:  2012-11-26       Impact factor: 5.923

7.  The cellular prion protein PrP(c) is involved in the proliferation of epithelial cells and in the distribution of junction-associated proteins.

Authors:  Etienne Morel; Stéphane Fouquet; Carine Strup-Perrot; Cathy Pichol Thievend; Cathy Pichol Thievend; Constance Petit; Damarys Loew; Anne-Marie Faussat; Lucile Yvernault; Martine Pinçon-Raymond; Jean Chambaz; Monique Rousset; Sophie Thenet; Caroline Clair
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.